Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Shuju Feng"'
Publikováno v:
International Breastfeeding Journal, Vol 18, Iss 1, Pp 1-8 (2023)
Abstract Background The breastfeeding rates of late preterm infants are lower than both term and extremely preterm infants. To explore the interventions of increasing full breast milk feeding rate of hospitalized late preterm infants on the 7th day a
Externí odkaz:
https://doaj.org/article/6aecc14bc8fc4ef7a7db09a3a2cb2696
Autor:
Shuju Feng, Xiaowen Liang, Miguel A Cruz, Hangoc Vu, Zhou Zhou, Naresh Pemmaraju, Jing-Fei Dong, Michael H Kroll, Vahid Afshar-Kharghan
Publikováno v:
PLoS ONE, Vol 8, Iss 8, p e73715 (2013)
Complement factor H (fH) is a plasma protein that regulates activation of the alternative pathway, and mutations in fH are associated with a rare form of thrombotic microangiopathy (TMA), known as atypical hemolytic uremic syndrome (aHUS). A more com
Externí odkaz:
https://doaj.org/article/45d0d74a491a40a38598b930247fe0f1
Publikováno v:
Pain Management Nursing. 22:668-673
Background Venipuncture is a common procedure in the neonatal intensive care unit (NICU) and causes significant pain for neonates. Aim To evaluate the effect of maternal voice on pain caused by venipuncture (including peripheral venipuncture and femo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::341cb65996ec16bfcbe481149a082b21
https://doi.org/10.1016/j.pmn.2021.01.002
https://doi.org/10.1016/j.pmn.2021.01.002
Autor:
Lisa S. Chen, Varsha Gandhi, Wei Qiao, William G. Wierda, Qi Wu, Prithviraj Bose, Xuelin Huang, Nichole Cruz, Yongying Jiang, Nitin Jain, Philip A. Thompson, Michael J. Keating, Michael H. Kroll, Shuju Feng
Publikováno v:
Blood. 132:2249-2259
Ibrutinib is highly efficacious and used at 420 mg/d for treatment of chronic lymphocytic leukemia (CLL). We previously demonstrated a decline in Bruton’s tyrosine kinase (BTK) protein levels in CLL cells after 1 cycle of ibrutinib, suggesting ibru
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8542190bf1e55673b2841862b7aac9f
https://doi.org/10.1182/blood-2018-06-860593
https://doi.org/10.1182/blood-2018-06-860593
Publikováno v:
Platelets. 27:716-718
Paraneoplastic thrombocytosis has been reported in different types of solid tumors, including ovarian epithelial cancer, and found to be associated with a worse outcome. Although the effect of cancer on increasing platelet counts is well documented,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::305d48d6e232983641bc499fb8c93972
https://doi.org/10.3109/09537104.2016.1174204
https://doi.org/10.3109/09537104.2016.1174204
Publikováno v:
Blood. 102:2122-2129
We examined the hypothesis that filamin A binding to the cytoplasmic tail of platelet glycoprotein Ibα (GpIbα) is regulated by pathologic shear stress and modulates von Willebrand factor (VWF)–induced platelet activation. To begin, we examined fi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::395af036154a91aebc3d59cbd0616a15
https://doi.org/10.1182/blood-2002-12-3805
https://doi.org/10.1182/blood-2002-12-3805
Autor:
Julio C. Reséndiz, Michael C. Berndt, Michael H. Kroll, Ketia A. Francis, Guilan Ji, Shuju Feng
Publikováno v:
Molecular Pharmacology. 63:639-645
Pathologically elevated shear stress triggers aspirin-insensitive platelet thrombosis. Signaling mechanisms involved in shear-induced platelet thrombosis are not well understood. To investigate these, we examined the hypothesis that functionally impo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82ad5666822edd77728dc28579424a48
https://doi.org/10.1124/mol.63.3.639
https://doi.org/10.1124/mol.63.3.639
Publikováno v:
Blood. 125(6)
Several complement proteins interact with hemostatic factors. We discovered that von Willebrand factor (VWF) acts as a cofactor for factor I–mediated cleavage of complement C3b, thereby shutting down complement activation. The complement regulatory
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd535aa755d6b867ff34fc786d178c32
https://pubmed.ncbi.nlm.nih.gov/25655456
https://pubmed.ncbi.nlm.nih.gov/25655456
Publikováno v:
Thrombosis Research. 102:133-142
The extracellular domain of glycoprotein (Gp) Ibalpha serves as the von Willebrand factor (vWf) receptor that triggers shear stress-dependent platelet aggregation. Its intracellular domain associates with actin-binding protein-280 (filamin 1a) that b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09dcd1be2aa0a471c43e16c3f3fbfb28
https://doi.org/10.1016/s0049-3848(01)00243-2
https://doi.org/10.1016/s0049-3848(01)00243-2
Publikováno v:
Blood. 95:551-557
Shear stress causes the platelet glycoprotein (Gp) Ib/IX/V to bind to von Willebrand factor, resulting in platelet adhesion. GpIb/IX/V also functions to stimulate transmembranous signaling, leading to platelet activation and the expression of a ligan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9eb4d160cba394e94a5ee28454b2d8bb
https://doi.org/10.1182/blood.v95.2.551
https://doi.org/10.1182/blood.v95.2.551